Overview

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects

Status:
Completed
Trial end date:
2021-04-12
Target enrollment:
Participant gender:
Summary
A Phase 1a, Double Blind, Placebo-Controlled, Single-Center, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Blade Therapeutics